MARKET

AGMB

AGMB

AgomAb Therapeutics NV
NASDAQ
13.81
+0.38
+2.83%
After Hours: 13.81 0 0.00% 16:10 06/26 EDT
OPEN
12.82
PREV CLOSE
13.43
HIGH
14.06
LOW
12.50
VOLUME
96.41K
TURNOVER
--
52 WEEK HIGH
17.45
52 WEEK LOW
8.75
MARKET CAP
680.11M
P/E (TTM)
-9.1682
1D
5D
1M
3M
1Y
5Y
1D
Agomab Details NOV-ERA Phase 2b Trial Design for Ontunisertib in Fibrostenosing Crohn’s Disease
TipRanks · 3d ago
Agomab announces NOV-ERA study design
TipRanks · 3d ago
Agomab wins FDA alignment for NOV-ERA Phase 2b design in fibrostenosing Crohn’s disease
PUBT · 3d ago
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
Barchart · 3d ago
Weekly Report: what happened at AGMB last week (0615-0619)?
Weekly Report · 5d ago
Agomab initiated with a Buy at H.C. Wainwright
TipRanks · 5d ago
AGOMAB THERAPEUTICS NV <AGMB.O>: H.C. WAINWRIGHT INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $35
Reuters · 5d ago
U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon
Reuters · 5d ago
More
About AGMB
Agomab Therapeutics NV is a Belgium-based company. The Company is engaged in research and development services creating therapies for fibrotic and inflammatory diseases. Its activities include discovery research to identify drug candidates that act on pathways involved in fibrosis and tissue repair, such as organ restricted small molecules and growth factor targeting antibodies. The Company also carries out preclinical development, including work on programs, to evaluate drug behavior and readiness before entering human studies. In addition, It conducts clinical development services by sponsoring and managing trials for its pipeline, assessing safety, tolerability, pharmacokinetics, and pharmacodynamics.

Webull offers AgomAb Therapeutics NV stock information, including NASDAQ: AGMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AGMB stock methods without spending real money on the virtual paper trading platform.